Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1130333.RAV_akCP5HetxNXFyO1tkUI56lhQGALWhOmuIe0oxeiW4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1130333.RAV_akCP5HetxNXFyO1tkUI56lhQGALWhOmuIe0oxeiW4130_assertion type Assertion NP1130333.RAV_akCP5HetxNXFyO1tkUI56lhQGALWhOmuIe0oxeiW4130_head.
- NP1130333.RAV_akCP5HetxNXFyO1tkUI56lhQGALWhOmuIe0oxeiW4130_assertion description "[Knockdown of eIF5A2 sensitized bladder cancer cells to doxorubicin, prevented doxorubicin-induced EMT in BIU-87 cells, and encouraged mesenchymal-epithelial transition in J82 and UM-UC-3 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1130333.RAV_akCP5HetxNXFyO1tkUI56lhQGALWhOmuIe0oxeiW4130_provenance.
- NP1130333.RAV_akCP5HetxNXFyO1tkUI56lhQGALWhOmuIe0oxeiW4130_assertion evidence source_evidence_literature NP1130333.RAV_akCP5HetxNXFyO1tkUI56lhQGALWhOmuIe0oxeiW4130_provenance.
- NP1130333.RAV_akCP5HetxNXFyO1tkUI56lhQGALWhOmuIe0oxeiW4130_assertion SIO_000772 24262005 NP1130333.RAV_akCP5HetxNXFyO1tkUI56lhQGALWhOmuIe0oxeiW4130_provenance.
- NP1130333.RAV_akCP5HetxNXFyO1tkUI56lhQGALWhOmuIe0oxeiW4130_assertion wasDerivedFrom befree-2016 NP1130333.RAV_akCP5HetxNXFyO1tkUI56lhQGALWhOmuIe0oxeiW4130_provenance.
- NP1130333.RAV_akCP5HetxNXFyO1tkUI56lhQGALWhOmuIe0oxeiW4130_assertion wasGeneratedBy ECO_0000203 NP1130333.RAV_akCP5HetxNXFyO1tkUI56lhQGALWhOmuIe0oxeiW4130_provenance.